Macrogen Acquires Patent Rights for Cancer Stem Cells
[Asia Economy Reporter Park Jihwan] Macrogen announced on the 17th that it has acquired a patent related to the detection and diagnosis of cancer stem cells.
Hot Picks Today
!["Even If I Lose My Investment, the Government Will Cover It"... The Fund Attracting Retail Investors' Attention [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051609052165501_1778889921.jpg)
"Even If I Lose My Investment, the Government Will Cover It"... The Fund Attracting Retail Investors' Attention [Weekend Money]
- Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- AI Said to Eliminate Jobs, but This Role Sees 800% Surge in Hiring [Tech Talk]
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
The name of this patented technology is a cancer stem cell-specific biomarker. It pertains to a composition for detecting cancer stem cells present in glioma, glioblastoma, anaplastic glioblastoma, meningioma, pituitary adenoma, and neurofibroma.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
